| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/08/2004 | WO2004029281A2 Methods and compositions for rnai mediated inhibition of viral gene expression in mammals |
| 04/08/2004 | WO2004029280A2 Anti-hla assay and methods |
| 04/08/2004 | WO2004029278A2 Aav itr-mediated modulation |
| 04/08/2004 | WO2004029259A1 Baculovirus vector, method of constructing baculovirus vector and gene transfer method |
| 04/08/2004 | WO2004029258A1 Nucleic acid constructs for gene expression |
| 04/08/2004 | WO2004029257A1 Plants having changed development and a method for making the same |
| 04/08/2004 | WO2004029256A2 Vector for the production of transplastomic angiosperm plants |
| 04/08/2004 | WO2004029255A2 Squalene synthase 8sqs9 gen |
| 04/08/2004 | WO2004029253A2 Nucleic acid sequences coding for proteolytic enzymes in the form of specific proteases, corresponding polypeptides and use of the same |
| 04/08/2004 | WO2004029252A2 A gene encoding vitamin b6 phosphate phosphatase and use thereof |
| 04/08/2004 | WO2004029251A1 Fructosylamine oxidase |
| 04/08/2004 | WO2004029250A1 Dna encoding flavin-adenine-dinucleotide-dependent-d-erythronate-4-phosphate-dehydrogenase, pdxr, and microbial production of vitamin b6 |
| 04/08/2004 | WO2004029249A1 Immunoglobulin compositions and methods |
| 04/08/2004 | WO2004029248A1 Tumor antigen protein and utilization thereof |
| 04/08/2004 | WO2004029247A1 Nuclear receptor transcriptional corepressor and uses thereof |
| 04/08/2004 | WO2004029245A1 Method for designing peptides |
| 04/08/2004 | WO2004029244A1 Animal cells having chimeric receptor and utilization thereof |
| 04/08/2004 | WO2004029243A1 Method of predicting genetic risk for hypertension |
| 04/08/2004 | WO2004029242A1 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same |
| 04/08/2004 | WO2004029235A2 Aldehyde dehydrogenase gene |
| 04/08/2004 | WO2004029234A1 Bhyd gene |
| 04/08/2004 | WO2004029232A2 Acc gene |
| 04/08/2004 | WO2004029229A2 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/08/2004 | WO2004029225A2 Detection of modular polyketide synthase gene clusters |
| 04/08/2004 | WO2004029224A2 Methods of engineering spatially conserved motifs in polypeptides |
| 04/08/2004 | WO2004029223A2 Polynucleotide synthesis and labeling by kinetic sampling ligation |
| 04/08/2004 | WO2004029222A2 Pathogen-responsive genes, promoters, regulatory elements, and methods of use for same |
| 04/08/2004 | WO2004029220A2 Synthetic genes |
| 04/08/2004 | WO2004029219A2 Cell-based rna interference and related methods and compositions |
| 04/08/2004 | WO2004029218A2 Receptors and membrane-associated proteins |
| 04/08/2004 | WO2004029215A2 Conditional gene expression using rnai |
| 04/08/2004 | WO2004029213A2 Compositions and methods for delivery of short interfering rna and short hairpin rna |
| 04/08/2004 | WO2004029212A2 In vivo gene silencing by chemically modified and stable sirna |
| 04/08/2004 | WO2004029197A2 Co-stimulatory molecules |
| 04/08/2004 | WO2004029093A2 Humanized anti-granulocyte mn-3 antibody and uses thereof |
| 04/08/2004 | WO2004029089A2 Novel angiogenesis target and uses thereof |
| 04/08/2004 | WO2004029087A2 Bitter taste receptors |
| 04/08/2004 | WO2004029086A2 Regulation of human calcium-independent alpha-latrotoxin receptor homolog 3 |
| 04/08/2004 | WO2004029085A2 METHOD FOR THE RATIONAL MUTAGENESIS OF A/ss T CELL RECEPTORS AND CORRESPONDINGLY MUTATED MDM2 PROTEIN-SPECIFIC A/ss T-CELL RECEPTORS |
| 04/08/2004 | WO2004029084A2 Lipase inhibitors and uses thereof |
| 04/08/2004 | WO2004029082A1 Antibacterial substance produced by lactic acid bacterium |
| 04/08/2004 | WO2004029070A2 Methods for blocking adipocyte differentiation and triglyceride accumulation with dual-specificity tyrosine- (y) - phosphorylation regulated kinase 4 (dyrk4) inhibitors |
| 04/08/2004 | WO2004028635A1 Ocular gene therapy |
| 04/08/2004 | WO2004028562A2 Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats |
| 04/08/2004 | WO2004028558A1 Preventives/remedies for neurodegenerative disease |
| 04/08/2004 | WO2004028552A1 Method for inducing mammary epithelial cell differentiation |
| 04/08/2004 | WO2004028479A2 Nouvelles compositions et methodes de traitement du psoriasis |
| 04/08/2004 | WO2004028478A2 Functional mutations in respiratory syncytial virus |
| 04/08/2004 | WO2004028471A2 Influenza therapeutic |
| 04/08/2004 | WO2004028467A2 Diagnosis of bovine viral diarrhea virus |
| 04/08/2004 | WO2004028464A2 Methods and compositions for modification of splicing of pre-mrna |
| 04/08/2004 | WO2004028458A2 Antisense modulation of microsomal prostaglandin e2 synthase expression |
| 04/08/2004 | WO2004028447A2 Novel compositions and methods for the treatment of psoriasis |
| 04/08/2004 | WO2004028442A2 Use of excipients to increase dna uptake by swine muscle cells |
| 04/08/2004 | WO2004028243A2 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 04/08/2004 | WO2004028239A2 Mammal model for autoimmune diseases with dysfunction of socs-1 gene |
| 04/08/2004 | WO2004020643A3 Regulated bacterial lysis for gene vaccine vector delivery and antigen release |
| 04/08/2004 | WO2004016730A3 Bacteria that can overproduce and secrete proteins |
| 04/08/2004 | WO2004013351A3 Target dna |
| 04/08/2004 | WO2004013155A3 Stabilisation of nucleic acids |
| 04/08/2004 | WO2004012887A3 Rotatable cutting tool |
| 04/08/2004 | WO2004012658A3 Method and device for protein delivery into cells |
| 04/08/2004 | WO2004011637A3 Modified adamts4 molecules and method of use thereof |
| 04/08/2004 | WO2004011624A9 Double stranded rna structures and constructs, and methods for generating and using the same |
| 04/08/2004 | WO2004011596A3 Method for preparing an extracellular matrix and its use for tumor cell culture |
| 04/08/2004 | WO2004011401A3 Method for making biochips |
| 04/08/2004 | WO2004009619A3 Protein complexes of the tip60 transcriptional activator protein |
| 04/08/2004 | WO2004007764A3 Chromosome 3, 5 and 11 genes involved in premature canities |
| 04/08/2004 | WO2004007702A3 Modulators of chloride intracellular channel 1 protein signaling ____________________________________________________________ |
| 04/08/2004 | WO2004006655A3 Nuclear fertility restorer genes and methods of use in plants |
| 04/08/2004 | WO2004005467A3 Expression of human interferon in transgenic chloroplasts |
| 04/08/2004 | WO2004005339A3 Cationic linear peptides having antibacterial and/or antifungal properties |
| 04/08/2004 | WO2004004687A3 Liposomal vaccine |
| 04/08/2004 | WO2004003152A3 Sos1 inhibitors |
| 04/08/2004 | WO2004003139A3 Modified shine-dalgarno sequences and methods of use thereof |
| 04/08/2004 | WO2004003016A3 Marked peptides having affinity for a phospholipid and uses |
| 04/08/2004 | WO2004003015A3 Peptides having affinity for a phospholipid and uses |
| 04/08/2004 | WO2004003006A3 Peptides having antimicrobial properties and compositions containing same in particular for preserving foods |
| 04/08/2004 | WO2004001069A3 Compositions and methods for detecting pathologies affecting neuromuscular transmission |
| 04/08/2004 | WO2004001004A3 Membrane associated tumor endothelium markers |
| 04/08/2004 | WO2004000877A3 Peptides derived from the rabies virus glycoprotein g, ligands of the low-affinity receptor of neurotrophins (p75ntr) and applications thereof |
| 04/08/2004 | WO2003107144A3 Systems and methods for predicting oligonucleotide melting temperatures (tms) |
| 04/08/2004 | WO2003106684A3 A method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 04/08/2004 | WO2003106620A3 Nucleic acid sequencing by signal stretching and data integration |
| 04/08/2004 | WO2003106619A3 Multifunctional polypeptides |
| 04/08/2004 | WO2003104490A3 Method for the simultaneous detection of hybridization and vaccination reactions |
| 04/08/2004 | WO2003104428A3 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/08/2004 | WO2003102578B1 High throughput cellular response assay using microarrays |
| 04/08/2004 | WO2003102185A3 Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules |
| 04/08/2004 | WO2003101184A3 Carotenoid synthesis |
| 04/08/2004 | WO2003100090A3 Protein c polymorphisms |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003100015A3 Polypeptide cleavage process |
| 04/08/2004 | WO2003100008A3 Neutralizing human anti-igfr antibody |
| 04/08/2004 | WO2003099860A8 Immunogenic composition and peptide sequences for prevention and treatment of an hsv condition |
| 04/08/2004 | WO2003095664A3 Pyrophosphorolysis activated polymerization (pap) |
| 04/08/2004 | WO2003093469A3 Methods for delivering nucleic acid molecules into cells and assessment thereof |
| 04/08/2004 | WO2003092600A3 Site specific listeria integration vectors and methods for using the same |
| 04/08/2004 | WO2003091273A3 Protein interaction system for multisubunit complexes |
| 04/08/2004 | WO2003087386A3 Methods for producing sulphurous fine chemicals by fermentation using meth-coding coryneform bacteria |